Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
G. Gary Tian
Observed names:
G Tian,
Gary G. Tian,
Gary Tian
Observed institutions:
University of Tennessee Health Science Center,
University of Colorado Cancer Center
OpenAlex ID:
A5066564429
Hepatobiliary Cancers, Version 2.2014
2014
·
Al B. Benson
, Michael I. D’Angelica
, et al.
·
Journal of the National Comprehensive Cancer Network
·
131
PDF
Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
2014
·
Lecia V. Sequist
, Phillippe Cassier
, et al.
·
Cancer Research
·
77
Abstract LB-122: A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors
2012
·
Jurgen Wolf
, Patricia M. LoRusso
, et al.
·
Cancer Research
·
49
Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
2014
·
Lecia V. Sequist
, Phillippe Cassier
, et al.
·
Kölner Universitäts PublikationsServer (Universität zu Köln)
·
37
Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer
2019
·
Yuefeng Wang
, Xinhua Yu
, et al.
·
Journal of the National Comprehensive Cancer Network
·
12
PDF
A phase Ib/II study evaluating the efficacy of doxorubicin (D) with or without a human anti-PDGFRα monoclonal antibody olaratumab (IMC-3G3) in the treatment of advanced soft tissue sarcoma (STS).
2012
·
William D. Tap
, Brian Andrew Van Tine
, et al.
·
Journal of Clinical Oncology
·
2
NA
2024
·
W Jiao
, W Jiao
, et al.
·
immuneACCESS
Show more works
View as search
Works count:
7
Citation count:
308
H-index:
5
I10-index:
5
Year
Topic
Type
